Nexgel (NXGL) Liabilities and Shareholders Equity (2018 - 2025)

Nexgel's Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $10.5 million for Q4 2025.

• Quarterly Liabilities and Shareholders Equity fell 4.75% year-over-year to $10.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.2 million (up 1.23% YoY) and the FY2025 annual result came in at $10.5 million, down 4.75% from the prior year.
• Liabilities and Shareholders Equity was $10.5 million for Q4 2025 at Nexgel, down from $11.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $17.0 million in Q4 2021 and bottomed at $3.4 million in Q1 2021.
• A 5-year average of $10.2 million and a median of $10.4 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2021 — Liabilities and Shareholders Equity soared 652.46% — and 2022, when it tumbled 39.02%.
• Nexgel's Liabilities and Shareholders Equity stood at $17.0 million in 2021, then tumbled by 39.02% to $10.4 million in 2022, then retreated by 3.88% to $10.0 million in 2023, then grew by 10.33% to $11.0 million in 2024, then dropped by 4.75% to $10.5 million in 2025.
• Business Quant data shows NXGL's Liabilities and Shareholders Equity at $10.5 million in Q4 2025, $11.6 million in Q3 2025, and $9.7 million in Q2 2025.